These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


171 related items for PubMed ID: 33671923

  • 1. Preparation and Bioevaluation of Novel 99mTc-Labeled Complexes with a 2-Nitroimidazole HYNIC Derivative for Imaging Tumor Hypoxia.
    Ruan Q, Gan Q, Zhang X, Fang S, Zhang J.
    Pharmaceuticals (Basel); 2021 Feb 15; 14(2):. PubMed ID: 33671923
    [Abstract] [Full Text] [Related]

  • 2. Synthesis and Bioevaluation of Novel Technetium-99m-Labeled Complexes with Norfloxacin HYNIC Derivatives for Bacterial Infection Imaging.
    Jiang Y, Fang S, Feng J, Ruan Q, Zhang J.
    Mol Pharm; 2023 Jan 02; 20(1):630-640. PubMed ID: 36398935
    [Abstract] [Full Text] [Related]

  • 3. Preparation and evaluation of 99mTc-labeled HYNIC-palbociclib analogs for cyclin-dependent kinase 4/6-positive tumor imaging.
    Gan Q, Song X, Zhang X, Zhang J.
    Eur J Med Chem; 2020 Feb 15; 188():112032. PubMed ID: 31926467
    [Abstract] [Full Text] [Related]

  • 4. [99mTc]HYNIC-RGD for imaging integrin alphavbeta3 expression.
    Decristoforo C, Faintuch-Linkowski B, Rey A, von Guggenberg E, Rupprich M, Hernandez-Gonzales I, Rodrigo T, Haubner R.
    Nucl Med Biol; 2006 Nov 15; 33(8):945-52. PubMed ID: 17127166
    [Abstract] [Full Text] [Related]

  • 5. Effects of coligand variation on the in vivo characteristics of Tc-99m-labeled interleukin-8 in detection of infection.
    Rennen HJ, van Eerd JE, Oyen WJ, Corstens FH, Edwards DS, Boerman OC.
    Bioconjug Chem; 2002 Nov 15; 13(2):370-7. PubMed ID: 11906276
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of a (99m)Tc-labeled cyclic RGD tetramer for noninvasive imaging integrin alpha(v)beta3-positive breast cancer.
    Liu S, Hsieh WY, Jiang Y, Kim YS, Sreerama SG, Chen X, Jia B, Wang F.
    Bioconjug Chem; 2007 Nov 15; 18(2):438-46. PubMed ID: 17341108
    [Abstract] [Full Text] [Related]

  • 7. 99mTc-labeled bombesin(7-14)NH2 with favorable properties for SPECT imaging of colon cancer.
    Shi J, Jia B, Liu Z, Yang Z, Yu Z, Chen K, Chen X, Liu S, Wang F.
    Bioconjug Chem; 2008 Jun 15; 19(6):1170-8. PubMed ID: 18491928
    [Abstract] [Full Text] [Related]

  • 8. New and versatile ternary ligand system for technetium radiopharmaceuticals: water soluble phosphines and tricine as coligands in labeling a hydrazinonicotinamide-modified cyclic glycoprotein IIb/IIIa receptor antagonist with 99mTc.
    Edwards DS, Liu S, Barrett JA, Harris AR, Looby RJ, Ziegler MC, Heminway SJ, Carroll TR.
    Bioconjug Chem; 1997 Jun 15; 8(2):146-54. PubMed ID: 9095354
    [Abstract] [Full Text] [Related]

  • 9. Coligand effects on the solution stability, biodistribution and metabolism of the (99m)Tc-labeled cyclic RGDfK tetramer.
    Liu S, Kim YS, Hsieh WY, Gupta Sreerama S.
    Nucl Med Biol; 2008 Jan 15; 35(1):111-21. PubMed ID: 18158950
    [Abstract] [Full Text] [Related]

  • 10. Effect of coligands on biodistribution characteristics of ternary ligand 99mTc complexes of a HYNIC-conjugated cyclic RGDfK dimer.
    Liu S, Hsieh WY, Kim YS, Mohammed SI.
    Bioconjug Chem; 2005 Jan 15; 16(6):1580-8. PubMed ID: 16287258
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of 99mTc-labeled cyclic RGD dimers: impact of cyclic RGD peptides and 99mTc chelates on biological properties.
    Zhou Y, Kim YS, Lu X, Liu S.
    Bioconjug Chem; 2012 Mar 21; 23(3):586-95. PubMed ID: 22369387
    [Abstract] [Full Text] [Related]

  • 12. Formulation and Preclinical Testing of Tc-99m-Labeled HYNIC-Glc-FAPT as a FAP-Targeting Tumor Radiotracer.
    Yang X, Li G, Ruan C, Hu K, Tang G.
    Bioconjug Chem; 2023 Nov 15; 34(11):2133-2143. PubMed ID: 37874952
    [Abstract] [Full Text] [Related]

  • 13. Improving tumor-targeting capability and pharmacokinetics of (99m)Tc-labeled cyclic RGD dimers with PEG(4) linkers.
    Wang L, Shi J, Kim YS, Zhai S, Jia B, Zhao H, Liu Z, Wang F, Chen X, Liu S.
    Mol Pharm; 2009 Nov 15; 6(1):231-45. PubMed ID: 19067525
    [Abstract] [Full Text] [Related]

  • 14. Evaluation of K(HYNIC)(2) as a bifunctional chelator for (99m)Tc-labeling of small biomolecules.
    Ji S, Zhou Y, Shao G, Liu S.
    Bioconjug Chem; 2013 Apr 17; 24(4):701-11. PubMed ID: 23521129
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Rational Design and Comparison of Novel 99mTc-Labeled FAPI Dimers for Visualization of Multiple Tumor Types.
    Meng L, Fang J, Zhang J, Li H, Xia D, Zhuang R, Chen H, Huang J, Li Y, Zhang X, Guo Z.
    J Med Chem; 2024 May 23; 67(10):8460-8472. PubMed ID: 38717104
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. (99m)Tc-Galacto-RGD2: a novel 99mTc-labeled cyclic RGD peptide dimer useful for tumor imaging.
    Ji S, Czerwinski A, Zhou Y, Shao G, Valenzuela F, Sowiński P, Chauhan S, Pennington M, Liu S.
    Mol Pharm; 2013 Sep 03; 10(9):3304-14. PubMed ID: 23875883
    [Abstract] [Full Text] [Related]

  • 20. [99mTc]-labeling and evaluation of a new linear peptide for imaging of glioblastoma as a αvβ3-positive tumor.
    Kaihani S, Sadeghzadeh N, Abediankenari S, Abedi SM.
    Ann Nucl Med; 2022 Nov 03; 36(11):976-985. PubMed ID: 36097232
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.